Efficacy of a Streptococcus iniae modified bacterin delivered using Oralject™ technology in Nile tilapia (Oreochromis niloticus)
- 31 May 2006
- journal article
- Published by Elsevier BV in Aquaculture
- Vol. 255 (1-4), 151-156
- https://doi.org/10.1016/j.aquaculture.2005.12.016
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Systemic and mucosal antibody response in tilapia, Oreochromis niloticus (L.), following immunization with Flavobacterium columnareJournal of Fish Diseases, 2004
- Oral immunization using alginate microparticles as a useful strategy for booster vaccination against fish lactoccocosisAquaculture, 2004
- Efficacy of oral reimmunisation after immersion vaccination against Vibrio vulnificus in farmed European eelsAquaculture, 2004
- Characterisation of mucosal and systemic immune responses in rainbow trout (Oncorhynchus mykiss) using surface plasmon resonanceFish & Shellfish Immunology, 2000
- Efficacy of single and combined Streptococcus iniae isolate vaccine administered by intraperitoneal and intramuscular routes in tilapia (Oreochromis niloticus)Aquaculture, 2000
- Use of a lipid-emulsion carrier for immunisation of dab (Limanda limanda) by bath and oral routes: an assessment of systemic and mucosal antibody responsesAquaculture, 2000
- Development and efficacy of a vaccine against Streptococcus iniae infection in farmed rainbow troutVeterinary Immunology and Immunopathology, 1997
- Vaccination with whole-cell vaccine and bacterial protein extract protects tilapia against Streptococcus difficile meningoencephalitisVaccine, 1995
- Systemic and mucosal immune responses to enterically delivered antigen in Oreochromis mossambicusFish & Shellfish Immunology, 1994
- Bacterial vaccines for fishAnnual Review of Fish Diseases, 1993